Impact of centralization of pancreatic cancer surgery on resection rates and survival
G.A. Gooiker(Leiden University Medical Center), Michel W.J.M. Wouters(The Netherlands Cancer Institute), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Olivier R. Busch(Amsterdam Neuroscience), V.E.P.P. Lemmens(Erasmus MC), Bert A. Bonsing(Leiden University Medical Center), I. Quintus Molenaar(Utrecht University), Ignace H. J. T. de Hingh(Radboud University Nijmegen), Marc G. Besselink(Amsterdam Neuroscience)
Cited by 267
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
|New England Journal of Medicine|2018|1.4k